Monument Therapeutics
UKEntry
2024
Hold
2yr
Status
Active
Who owns Monument Therapeutics?
Monument Therapeutics is currently owned by Syndicate Room through Access EIS (2019 vintage), since 2024. Across its history, Monument Therapeutics has been through 2 private equity ownership periods, detailed in the timeline below.
Hand-verified · updated 2026-04-21
Most recent investor
Syndicate RoomAccess EIS · 2019 · Evergreen
2 ownership periods · full history below
Key facts
HQUK
SectorHealthcare
Ownership history
2 ownership periods · co-invest detected
Active
Co-invest · 2 holders · 2024 · present
Syndicate RoomActive
2024 · present(2yr) · Access EIS · 2019 · Evergreen
ACF InvestorsActive
2025 · present(1yr) · Angel CoFund · 2011 · VC
More from Access EIS
Other portfolio companies in the same fund.
More PE-backed in Biotech
Comparable biotech deals from other GPs.
FranceTrack Monument Therapeutics
Save this record to your watchlist and pick up your research where you left off. No spam.
Get the full record on Monument Therapeutics.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue